National Consumers League supports Questran switch contingent on consumer education.
This article was originally published in The Tan Sheet
Executive Summary
NATIONAL CONSUMERS LEAGUE SUPPORT FOR QUESTRAN SWITCH CONTINGENT on "several levels of consumer education and information," NCL President Linda Golodner said at the May 13 FDA advisory committee meeting on the switch. She emphasized that "to educate the consumer about the safe and effective use of this medication as an OTC drug will take careful and continued reinforcement by health professionals and by the industry."